Literature DB >> 11891282

Covalent modification of proteins by cocaine.

Shi-Xian Deng1, Narine Bharat, Marian C Fischman, Donald W Landry.   

Abstract

Cocaine covalently modifies proteins through a reaction in which the methyl ester of cocaine acylates the epsilon-amino group of lysine residues. This reaction is highly specific in vitro, because no other amino acid reacts with cocaine, and only cocaine's methyl ester reacts with the lysine side chain. Covalently modified proteins were present in the plasma of rats and human subjects chronically exposed to cocaine. Modified endogenous proteins are immunogenic, and specific antibodies were elicited in mouse and detected in the plasma of human subjects. Covalent modification of proteins could explain cocaine's autoimmune effects and provide a new biochemical approach to cocaine's long-term actions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11891282      PMCID: PMC122537          DOI: 10.1073/pnas.042700599

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

Review 1.  Cocaine-associated cerebral vasculitis.

Authors:  P A Merkel; W J Koroshetz; M C Irizarry; M E Cudkowicz
Journal:  Semin Arthritis Rheum       Date:  1995-12       Impact factor: 5.532

Review 2.  Drugs associated with vasculitis.

Authors:  P A Merkel
Journal:  Curr Opin Rheumatol       Date:  1998-01       Impact factor: 5.006

3.  Off-the-shelf proteins that rival tailor-made antibodies as catalysts.

Authors:  F Hollfelder; A J Kirby; D S Tawfik
Journal:  Nature       Date:  1996-09-05       Impact factor: 49.962

4.  Antibody-catalyzed degradation of cocaine.

Authors:  D W Landry; K Zhao; G X Yang; M Glickman; T M Georgiadis
Journal:  Science       Date:  1993-03-26       Impact factor: 47.728

5.  Cocaine and immunocompetence: possible role of reactive metabolites.

Authors:  M P Holsapple; R A Matulka; E D Stanulis; S D Jordan
Journal:  Adv Exp Med Biol       Date:  1993       Impact factor: 2.622

Review 6.  Alpha2-macroglobulin: an evolutionarily conserved arm of the innate immune system.

Authors:  P B Armstrong; J P Quigley
Journal:  Dev Comp Immunol       Date:  1999 Jun-Jul       Impact factor: 3.636

7.  Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects.

Authors:  N D Volkow; G J Wang; J S Fowler; J Logan; S J Gatley; R Hitzemann; A D Chen; S L Dewey; N Pappas
Journal:  Nature       Date:  1997-04-24       Impact factor: 49.962

8.  Role of dopamine D1 receptors in cocaine lethality.

Authors:  M D Schechter; S M Meehan
Journal:  Pharmacol Biochem Behav       Date:  1995 Jun-Jul       Impact factor: 3.533

9.  Concentration of cocaine and metabolites in plasma of humans following intravenous administration and smoking of cocaine.

Authors:  D S Isenschmid; M W Fischman; R W Foltin; Y H Caplan
Journal:  J Anal Toxicol       Date:  1992 Sep-Oct       Impact factor: 3.367

10.  Simplified multidose preparation of iodine-123-beta-CIT: a marker for dopamine transporters.

Authors:  Y Zea-Ponce; R M Baldwin; M Laruelle; S Wang; J L Neumeyer; R B Innis
Journal:  J Nucl Med       Date:  1995-03       Impact factor: 10.057

View more
  12 in total

Review 1.  The future of vaccines in the management of addictive disorders.

Authors:  Frank M Orson; Berma M Kinsey; Rana A K Singh; Yan Wu; Tracie Gardner; Thomas R Kosten
Journal:  Curr Psychiatry Rep       Date:  2007-10       Impact factor: 5.285

2.  Spontaneous development of IgM anti-cocaine antibodies in habitual cocaine users: effect on IgG antibody responses to a cocaine cholera toxin B conjugate vaccine.

Authors:  Frank M Orson; Roger D Rossen; Xiaoyun Shen; Angel Y Lopez; Yan Wu; Thomas R Kosten
Journal:  Am J Addict       Date:  2013-02-01

3.  Probing active cocaine vaccination performance through catalytic and noncatalytic hapten design.

Authors:  Xiaoqing Cai; Timothy Whitfield; Mark S Hixon; Yanabel Grant; George F Koob; Kim D Janda
Journal:  J Med Chem       Date:  2013-04-29       Impact factor: 7.446

Review 4.  Systems-level view of cocaine addiction: the interconnection of the immune and nervous systems.

Authors:  Christina C Marasco; Cody R Goodwin; Danny G Winder; Nicole L Schramm-Sapyta; John A McLean; John P Wikswo
Journal:  Exp Biol Med (Maywood)       Date:  2014-06-05

5.  Cocaine increases human immunodeficiency virus type 1 neuroinvasion through remodeling brain microvascular endothelial cells.

Authors:  Milan Fiala; Amy J Eshleman; John Cashman; Justin Lin; Albert S Lossinsky; Vannina Suarez; Wendy Yang; Jun Zhang; Waldemar Popik; Elyse Singer; Francesco Chiappelli; Eva Carro; Martin Weinand; Marlys Witte; James Arthos
Journal:  J Neurovirol       Date:  2005-07       Impact factor: 2.643

Review 6.  Substance abuse vaccines.

Authors:  Frank M Orson; Berma M Kinsey; Rana A K Singh; Yan Wu; Tracie Gardner; Thomas R Kosten
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

Review 7.  Vaccines for cocaine abuse.

Authors:  Frank M Orson; Berma M Kinsey; Rana A K Singh; Yan Wu; Thomas R Kosten
Journal:  Hum Vaccin       Date:  2009-04-20

Review 8.  Can you vaccinate against substance abuse?

Authors:  Thomas R Kosten; Coreen B Domingo
Journal:  Expert Opin Biol Ther       Date:  2013-04-18       Impact factor: 4.388

9.  Probing the effects of hapten stability on cocaine vaccine immunogenicity.

Authors:  Xiaoqing Cai; Timothy Whitfield; Amira Y Moreno; Yanabel Grant; Mark S Hixon; George F Koob; Kim D Janda
Journal:  Mol Pharm       Date:  2013-10-04       Impact factor: 4.939

Review 10.  The future potential for cocaine vaccines.

Authors:  Frank M Orson; Rongfu Wang; Stephen Brimijoin; Berma M Kinsey; Rana Ak Singh; Muthu Ramakrishnan; Helen Y Wang; Thomas R Kosten
Journal:  Expert Opin Biol Ther       Date:  2014-05-16       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.